Welcome to our dedicated page for Transcat news (Ticker: TRNS), a resource for investors and traders seeking the latest updates and insights on Transcat stock.
Transcat Inc (TRNS) provides essential calibration services and compliance solutions for life sciences, pharmaceutical, and industrial sectors. This news hub offers investors and industry professionals direct access to official corporate announcements and strategic developments.
Find timely updates on regulatory compliance achievements, service network expansions, and financial performance. Our curated collection includes earnings reports, instrumentation innovations, and quality assurance milestones that demonstrate Transcat's market leadership.
Key content areas cover FDA-related compliance updates, ISO/IEC 17025 accreditation developments, distribution partnerships, and operational enhancements across Transcat's North American service centers. All materials maintain strict adherence to factual reporting standards.
Bookmark this page for streamlined access to Transcat's verified announcements. Check regularly for updates impacting measurement services, laboratory instrument validation, and industrial compliance solutions in regulated markets.
Transcat (Nasdaq: TRNS) said management will attend three investor conferences in November 2025: the Baird 2025 Global Industrial Conference (Nov 11-12, Chicago), the Raymond James Sonoma Small Cap Summit (Nov 17, Sonoma), and the Stephens Annual Investment Conference (Nov 19, Nashville).
CEO Lee Rudow and CFO Thomas Barbato will host one-on-one investor meetings at Baird and Raymond James; Rudow will present at Baird on Nov 11, 2025 at 8:30 a.m. Central. CFO Thomas Barbato and COO Michael West will host one-on-one meetings at the Stephens conference. Contact TRNS@mzgroup.us or call (949) 491-8235 to request a meeting.
Transcat (Nasdaq: TRNS) will release its second quarter fiscal 2026 results for the period ended September 27, 2025 after market close on Monday, November 3, 2025.
Management will host a conference call and webcast on November 3, 2025 at 4:30 p.m. ET with President & CEO Lee Rudow and CFO Thomas Barbato to review financial and operating results, corporate strategy and outlook, followed by a Q&A.
Dial-in numbers and a webcast link are provided for live access. A telephonic replay will be available from 8:30 p.m. ET on November 3 through November 10, 2025, and the webcast replay and transcript will be posted to the company's investor relations site.
Transcat (NASDAQ: TRNS), a leader in test measurement, control and calibration, announced its participation in the D.A. Davidson 24th Annual Diversified Industrials & Services Conference. The event will take place from September 17-19, 2025, at the Four Seasons Hotel in Nashville.
CEO Lee Rudow and CFO Thomas Barbato will conduct in-person one-on-one meetings with investors throughout the conference. Interested parties can schedule meetings through their D.A. Davidson representative or by contacting TRNS@mzgroup.us.
Transcat (NASDAQ: TRNS), a leader in test measurement, control and calibration, announced that CEO Lee D. Rudow will retire in March 2026 after 14 years with the company, including over a decade as CEO. Following his retirement, Rudow will transition to an advisory role until 2027 to ensure continuity.
The Board has initiated a search for the next CEO, considering both internal and external candidates. CFO Tom Barbato confirmed strong financial performance and highlighted recent acquisitions of Martin Calibration and Essco, expecting to return to high single-digit Service organic revenue growth in the second half of fiscal 2026.
Transcat (NASDAQ:TRNS) reported strong fiscal Q1 2026 results with significant growth across key metrics. The company achieved consolidated revenue of $76.4 million, up 14.6% year-over-year, with Service revenue increasing 12.3% to $49.1 million and Distribution revenue growing 19% to $27.3 million.
The company's Adjusted EBITDA rose 15.2% to $11.8 million, while Distribution segment achieved record gross margins of 35.2%. Notably, Transcat announced the acquisition of Essco Calibration Laboratory, their largest deal to date, which adds $22 million in annual revenue and strengthens their presence in the New England market.
To support growth initiatives, Transcat secured a new 5-Year $150 Million syndicated credit facility, nearly doubling their previous capacity. The company maintains a strong balance sheet with a 0.82x leverage ratio and expects high single-digit organic revenue growth in the second half of fiscal 2026.
Transcat (NASDAQ: TRNS) has completed its largest-ever acquisition, purchasing Essco Calibration Laboratory for $84 million in cash. Essco, an ISO-17025 Accredited calibration laboratory based in the Boston metro area, generates over $22 million in annual revenue with EBITDA margins exceeding 25%.
The strategic acquisition positions Transcat as the dominant player in New England's calibration services market. Essco brings 113 employees and serves various sectors including Medical, Life Science, Aerospace & Defense, and Industrial. The deal was financed through Transcat's new $150 million syndicated credit facility led by M&T Bank and Wells Fargo Bank.
This acquisition follows Transcat's purchase of Martin Calibration in December, with both deals expected to contribute approximately $50 million in annualized revenue focused on core calibration services.
Transcat (NASDAQ: TRNS), a leader in test measurement, control and calibration, has secured a new $150 million syndicated secured credit facility with a 5-year term. The facility is led by M&T Bank and includes Wells Fargo and Bank of America as additional lenders.
The new credit facility, which replaces an existing $80 million facility, includes revolving loan options, swingline loans, and letters of credit. It features enhanced flexibility with a temporary leverage ratio covenant increase for permitted acquisitions. The facility will be used to refinance the previous facility, fund strategic acquisitions, and provide working capital for general corporate purposes.
Transcat (Nasdaq: TRNS), a leader in test measurement, control and calibration, has scheduled its first quarter fiscal year 2026 earnings conference call for Thursday, August 7, 2025, at 11:00 a.m. ET. The company will release its financial results after market close on Wednesday, August 6, 2025.
The conference call will include a discussion of the company's financial results, corporate strategy, and outlook, followed by a Q&A session. Participants can join via toll-free number (800) 267-6316 or international number (203) 518-9783 using Conference ID: TRANSCAT. A webcast replay will be available until August 14, 2025.